BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 21931106)

  • 1. Glucose tolerance status and risk of dementia in the community: the Hisayama study.
    Ohara T; Doi Y; Ninomiya T; Hirakawa Y; Hata J; Iwaki T; Kanba S; Kiyohara Y
    Neurology; 2011 Sep; 77(12):1126-34. PubMed ID: 21931106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Glucose tolerance status and risk of dementia in the community: the Hisayama study].
    Ohara T
    Seishin Shinkeigaku Zasshi; 2013; 115(1):90-7. PubMed ID: 23691800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between glucose tolerance level and cancer death in a general Japanese population: the Hisayama Study.
    Hirakawa Y; Ninomiya T; Mukai N; Doi Y; Hata J; Fukuhara M; Iwase M; Kitazono T; Kiyohara Y
    Am J Epidemiol; 2012 Nov; 176(10):856-64. PubMed ID: 23100249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of oral glucose tolerance test in pregnant women with abnormal glucose metabolism.
    Yang HX; Gao XL; Dong Y; Shi CY
    Chin Med J (Engl); 2005 Jun; 118(12):995-9. PubMed ID: 15978207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative oral glucose tolerance testing in vascular surgery patients: long-term cardiovascular outcome.
    van Kuijk JP; Dunkelgrun M; Schreiner F; Flu WJ; Galal W; van Domburg RT; Hoeks SE; van Gestel YR; Bax JJ; Poldermans D
    Am Heart J; 2009 May; 157(5):919-25. PubMed ID: 19376322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of glucose tolerance status on development of ischemic stroke and coronary heart disease in a general Japanese population: the Hisayama study.
    Doi Y; Ninomiya T; Hata J; Fukuhara M; Yonemoto K; Iwase M; Iida M; Kiyohara Y
    Stroke; 2010 Feb; 41(2):203-9. PubMed ID: 19940278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab).
    Barr EL; Zimmet PZ; Welborn TA; Jolley D; Magliano DJ; Dunstan DW; Cameron AJ; Dwyer T; Taylor HR; Tonkin AM; Wong TY; McNeil J; Shaw JE
    Circulation; 2007 Jul; 116(2):151-7. PubMed ID: 17576864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of progression to type 2 diabetes based on relationship between postload plasma glucose and fasting plasma glucose.
    Abdul-Ghani MA; Williams K; DeFronzo R; Stern M
    Diabetes Care; 2006 Jul; 29(7):1613-8. PubMed ID: 16801587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Day-to-Day Blood Pressure Variability and Risk of Dementia in a General Japanese Elderly Population: The Hisayama Study.
    Oishi E; Ohara T; Sakata S; Fukuhara M; Hata J; Yoshida D; Shibata M; Ohtsubo T; Kitazono T; Kiyohara Y; Ninomiya T
    Circulation; 2017 Aug; 136(6):516-525. PubMed ID: 28784822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knee height and arm span: a reflection of early life environment and risk of dementia.
    Huang TL; Carlson MC; Fitzpatrick AL; Kuller LH; Fried LP; Zandi PP
    Neurology; 2008 May; 70(19 Pt 2):1818-26. PubMed ID: 18458216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relation between smoking and risk of dementia and Alzheimer disease: the Rotterdam Study.
    Reitz C; den Heijer T; van Duijn C; Hofman A; Breteler MM
    Neurology; 2007 Sep; 69(10):998-1005. PubMed ID: 17785668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postload plasma glucose and 30-year mortality among nondiabetic middle-aged men from the general population: the ERFORT Study.
    Meisinger C; Wölke G; Brasche S; Strube G; Heinrich J
    Ann Epidemiol; 2006 Jul; 16(7):534-9. PubMed ID: 16406244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum Soluble Triggering Receptor Expressed on Myeloid Cells 2 as a Biomarker for Incident Dementia: The Hisayama Study.
    Ohara T; Hata J; Tanaka M; Honda T; Yamakage H; Yoshida D; Inoue T; Hirakawa Y; Kusakabe T; Shibata M; Teraoka T; Kitazono T; Kanba S; Satoh-Asahara N; Ninomiya T
    Ann Neurol; 2019 Jan; 85(1):47-58. PubMed ID: 30485483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Criteria for previously undiagnosed diabetes and risk of mortality: 15-year follow-up of the Edinburgh Artery Study cohort.
    Wild SH; Smith FB; Lee AJ; Fowkes FG
    Diabet Med; 2005 Apr; 22(4):490-6. PubMed ID: 15787678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular risk factors for incident Alzheimer disease and vascular dementia: the Cache County study.
    Hayden KM; Zandi PP; Lyketsos CG; Khachaturian AS; Bastian LA; Charoonruk G; Tschanz JT; Norton MC; Pieper CF; Munger RG; Breitner JC; Welsh-Bohmer KA;
    Alzheimer Dis Assoc Disord; 2006; 20(2):93-100. PubMed ID: 16772744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physical activity and dementia risk in the elderly: findings from a prospective Italian study.
    Ravaglia G; Forti P; Lucicesare A; Pisacane N; Rietti E; Bianchin M; Dalmonte E
    Neurology; 2008 May; 70(19 Pt 2):1786-94. PubMed ID: 18094335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting isolated postchallenge hyperglycaemia: a new approach; Tehran Lipid and Glucose Study (TLGS).
    Hosseinpanah F; Rambod M; Reza Ghaffari HR; Azizi F
    Diabet Med; 2006 Sep; 23(9):982-9. PubMed ID: 16922704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of Type 2 diabetes in England and its association with baseline impaired fasting glucose: the Ely study 1990-2000.
    Forouhi NG; Luan J; Hennings S; Wareham NJ
    Diabet Med; 2007 Feb; 24(2):200-7. PubMed ID: 17257284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Midlife risk factors for subtypes of dementia: a nested case-control study in Taiwan.
    Chiang CJ; Yip PK; Wu SC; Lu CS; Liou CW; Liu HC; Liu CK; Chu CH; Hwang CS; Sung SF; Hsu YD; Chen CC; Liu SI; Yan SH; Fong CS; Chang SF; You SL; Chen CJ
    Am J Geriatr Psychiatry; 2007 Sep; 15(9):762-71. PubMed ID: 17623813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two hour plasma glucose is not unequivocally predictive for early death in men with impaired fasting glucose: more results from the Paris Prospective Study.
    Balkau B; Forhan A; Eschwège E
    Diabetologia; 2002 Sep; 45(9):1224-30. PubMed ID: 12242454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.